| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695090 | Gynecologic Oncology | 2017 | 8 Pages |
Abstract
This systematic review supports ORR as a possible surrogate clinical trial endpoint for OS in recurrent OC with at least second-line therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Mohammed Kashif Siddiqui, Jerzy Tyczynski, Ankit Pahwa, Ancilla W. Fernandes,